Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Nitrasanata Dharma Tbk. (JECX) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Nitrasanata Dharma Tbk.Trade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Nitrasanata Dharma Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Nitrasanata Dharma Tbk. trades at Rp1,330 (market cap 4.57T, 11.02M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp148 (market cap 576.7B, 3.48M 24h volume). The key difference: Nitrasanata Dharma Tbk. is far larger — about 7.9× UBC Medical Indonesia Tbk.'s market cap, and Nitrasanata Dharma Tbk. is more actively traded (11.02M versus 3.48M). Which is the better fit depends on your goals.

JECXLABS
Market Cap
4.57T576.7B
Volume
11.02M3.48M
Lot
110.19K34.82K
Turnover
15.12B522.79M
Average Price
1,372.09150.13
Value
15.12B522.79M
Indicative Equilibrium Price
1,330148
Indicative Equilibrium Volume
2.04K350

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

JECX
View details
LABS
View details

About Nitrasanata Dharma Tbk.

PT Nitrasanata Dharma Tbk (the Company) was established based on Notarial Deed No. 526 of Richardus Nangkih Sinulingga, S.H., dated November 28, 1990. The Company started its commercial operations in 1990. PT Magna Selaras Lestari is the controlling entity of the Company, and Dr. Darwan Madja Purba, SpM(K) as ultimate beneficial owner of the Company.

Read more on JECX

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS